Fox Run Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,637	Closed	-$400K	–	979
2025 Q2	$400K	Buy	+2,637	New	+$352K	0.07%	548
2023 Q2	–	Sell	-4,320	Closed	-$872K	–	743
2023 Q1	$872K	Buy	+4,320	New	+$979K	0.28%	90
2022 Q3	–	Sell	-2,549	Closed	-$545K	–	641
2022 Q2	$545K	Buy	+2,549	New	+$623K	0.27%	101
2020 Q3	–	Sell	-1,154	Closed	-$201K	–	198
2020 Q2	$201K	Buy	+1,154	New	+$184K	0.27%	215
2019 Q1	–	Sell	-7,116	Closed	-$805K	–	502
2018 Q4	$805K	Buy	+7,116	New	+$891K	0.43%	20
2018 Q2	–	Sell	-6,660	Closed	-$711K	–	707
2018 Q1	$711K	Buy	+6,660	New	+$718K	0.17%	190
2017 Q4	–	Sell	-4,400	Closed	-$475K	–	702
2017 Q3	$475K	Buy	+4,400	New	+$452K	0.13%	311
2017 Q2	–	Sell	-7,400	Closed	-$666K	–	664
2017 Q1	$666K	Sell	7,400 -2,700	-27%	-$229K	0.27%	97
2016 Q4	$770K	Buy	10,100 +1,200	+13%	+$91.1K	0.4%	26
2016 Q3	$742K	Sell	8,900 -300	-3%	-$25.1K	0.44%	20
2016 Q2	$758K	Buy	+9,200	New	+$758K	0.37%	30